Congratulations to Hongqi Pharmaceutical's B2 plant for passing GMP certification
Category:
Company News
Author:
Source:
Add time:2019-01-03 13:32
Summary:On December 27, 2018, the B2 plant of Hongqi Pharmaceuticals obtained the Certificate of Good Manufacturing Practice for Pharmaceutical Production issued by the Liaoning Provincial Drug Administration.
On December 27, 2018, the B2 plant of Hongqi Pharmaceuticals obtained the Certificate of Good Manufacturing Practice for Pharmaceutical Production issued by the Liaoning Provincial Drug Administration. In 2018, after rebuilding the plant and equipment and facilities, the production lines of four dosage forms including soft capsules in the B2 plant have met the requirements of the national drug production quality management standard.
In the future, the B2 plant will produce a variety of products including evening primrose soft capsules, nonoxynol suppositories, ethacridine lactate and other products, which will provide a solid foundation for the five-year strategic plan to enrich Hongqi's pharmaceutical product line and serve the expansion of peripheral products.
